Please wait while the formulary information is being retrieved.
CHANTIX (VARENICLINE TARTRATE)
- Smoking cessation
- Chantix Tablet
- Chantix Starting Month Box Tablets In Dose Pack
- Chantix Continuing Month Box Tablet
- By Indication
0.5 mg tablet
- 1 tablet (0.5 mg) with glass of water by oral route 2 times per day after meals for 3 days
1 mg tablet
- 1 tablet (1 mg) with glass of water by oral route 2 times per day after meals
Starting Month Box 0.5 mg (11)-1 mg (42) tablets in dose pack
- Dosage information is not available
Continuing Month Box 1 mg tablet
- 1 tablet (1 mg) with glass of water by oral route 2 times per day after meals
Smoking cessation
- 1 tablet (0.5 mg) with glass of water by oral route once daily after meals for 3 days
- 1 tablet (0.5 mg) with glass of water by oral route 2 times per day after meals for 3 days
- 2 tablets (1 mg) by oral route 2 times per day after meals with glass of water
- 2 tablets (1 mg) with glass of water by oral route 2 times per day after meals for 12 weeks
- 1 tablet (1 mg) with glass of water by oral route 2 times per day after meals
- 1 tablet (1 mg) with glass of water by oral route 2 times per day after meals for 12 weeks
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Bipolar disorder
- Depression
- Schizophrenia
- Seizure disorder
- Severe renal impairment
- Suicidal ideation
Severe
Moderate
- Acute coronary syndrome
- Acute myocardial infarction
- Alcohol intoxication
- Alcoholism
- Angina
- Cerebrovascular accident
- Increased cardiovascular event risk
- Peripheral vascular disease
- Transient cerebral ischemia
CHANTIX (VARENICLINE TARTRATE)
- Smoking cessation
- None
- Constipation
- Dream disorder
- Flatulence
- Headache disorder
- Insomnia
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Angina
- Acute abdominal pain
- Anorexia
- Drowsy
- Dyspepsia
- Dyspnea
- Fatigue
- Gastroesophageal reflux disease
- General weakness
- Hyperhidrosis
- Increased appetite
- Lethargy
- Malaise
- Nightmares
- Pruritus of skin
- Rhinorrhea
- Skin rash
- Upper respiratory infection
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Accidental injury
- Acute myocardial infarction
- Acute pancreatitis
- Alcohol intolerance
- Anemia
- Angioedema
- Cardiac arrhythmia
- Cerebrovascular accident
- Diabetes mellitus
- Drug-induced psychosis
- Erythema multiforme
- Homicidal ideation
- Hypersensitivity drug reaction
- Hypertension
- Manic disorder
- Seizure disorder
- Stevens-johnson syndrome
- Suicidal
- Suicidal ideation
- Thrombotic disorder
- Transient cerebral ischemia
- Unconsciousness
Less Severe
- Acne vulgaris
- Aggressive behavior
- Agitation
- Allergic rhinitis
- Arthralgias
- Asthma
- Back pain
- Behavioral disorders
- Chest pain
- Concentration difficulty
- Cramps
- Delusional disorder
- Depression
- Diarrhea
- Disturbance of attention
- Dizziness
- Drug-induced hot flash
- Dry skin
- Dysgeusia
- Eczema
- Edema
- Epistaxis
- Erectile dysfunction
- Flu-like symptoms
- Flushing
- Hallucinations
- Hostility
- Hyperglycemia
- Increased urinary frequency
- Libido changes
- Lymphadenopathy
- Menstrual disorder
- Mood changes
- Myalgias
- Nocturia
- Palpitations
- Panic disorder
- Paranoid disorder
- Peripheral vascular disease
- Polyuria
- Psoriasis
- Skin photosensitivity
- Sleep disorder
- Sleep walking disorder
- Symptoms of anxiety
- Tinnitus
- Toothache
- Urticaria
- Vertigo
- Visual changes
- Weight gain
Contraindicated
None
Severe Precaution
Varenicline
Risk of behavioral changes, suicidal ideation. No efficacy demonstrated in pediatric patients 16 years of age or younger.
- 1 Day – 17 Years
- Risk of behavioral changes, suicidal ideation. No efficacy demonstrated in pediatric patients 16 years of age or younger.
Management or Monitoring Precaution
None
Varenicline
- Severity Level:
2
- Additional Notes: Insuff human data avail; smoking during incr risk of oral cleft
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Varenicline
Insufficient human data; excreted in animals
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data; excreted in animals |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Smoking cessation | |
| F17 | Nicotine dependence |
| F17.2 | Nicotine dependence |
| F17.20 | Nicotine dependence, unspecified |
| F17.200 | Nicotine dependence, unspecified, uncomplicated |
| F17.201 | Nicotine dependence, unspecified, in remission |
| F17.203 | Nicotine dependence unspecified, with withdrawal |
| F17.208 | Nicotine dependence, unspecified, with other nicotine-induced disorders |
| F17.209 | Nicotine dependence, unspecified, with unspecified nicotine-induced disorders |
| F17.21 | Nicotine dependence, cigarettes |
| F17.210 | Nicotine dependence, cigarettes, uncomplicated |
| F17.211 | Nicotine dependence, cigarettes, in remission |
| F17.213 | Nicotine dependence, cigarettes, with withdrawal |
| F17.218 | Nicotine dependence, cigarettes, with other nicotine-induced disorders |
| F17.219 | Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders |
| O99.33 | Tobacco use disorder complicating pregnancy, childbirth, and the puerperium |
| O99.330 | Smoking (tobacco) complicating pregnancy, unspecified trimester |
| O99.331 | Smoking (tobacco) complicating pregnancy, first trimester |
| O99.332 | Smoking (tobacco) complicating pregnancy, second trimester |
| O99.333 | Smoking (tobacco) complicating pregnancy, third trimester |
| O99.334 | Smoking (tobacco) complicating childbirth |
| O99.335 | Smoking (tobacco) complicating the puerperium |
| Z87.891 | Personal history of nicotine dependence |
| 0-9 | A-Z |
|---|---|
| F17 | Nicotine dependence |
| F17.2 | Nicotine dependence |
| F17.20 | Nicotine dependence, unspecified |
| F17.200 | Nicotine dependence, unspecified, uncomplicated |
| F17.201 | Nicotine dependence, unspecified, in remission |
| F17.203 | Nicotine dependence unspecified, with withdrawal |
| F17.208 | Nicotine dependence, unspecified, with other nicotine-induced disorders |
| F17.209 | Nicotine dependence, unspecified, with unspecified nicotine-induced disorders |
| F17.21 | Nicotine dependence, cigarettes |
| F17.210 | Nicotine dependence, cigarettes, uncomplicated |
| F17.211 | Nicotine dependence, cigarettes, in remission |
| F17.213 | Nicotine dependence, cigarettes, with withdrawal |
| F17.218 | Nicotine dependence, cigarettes, with other nicotine-induced disorders |
| F17.219 | Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders |
| O99.33 | Tobacco use disorder complicating pregnancy, childbirth, and the puerperium |
| O99.330 | Smoking (tobacco) complicating pregnancy, unspecified trimester |
| O99.331 | Smoking (tobacco) complicating pregnancy, first trimester |
| O99.332 | Smoking (tobacco) complicating pregnancy, second trimester |
| O99.333 | Smoking (tobacco) complicating pregnancy, third trimester |
| O99.334 | Smoking (tobacco) complicating childbirth |
| O99.335 | Smoking (tobacco) complicating the puerperium |
| Z87.891 | Personal history of nicotine dependence |
Formulary Reference Tool